Subtopic Deep Dive
Metal Complex Cellular Uptake
Research Guide
What is Metal Complex Cellular Uptake?
Metal Complex Cellular Uptake studies the mechanisms by which anticancer metal complexes enter cells via transporters, aquation, and target organelles like mitochondria.
Researchers quantify uptake using ICP-MS and fluorescence microscopy to measure influx rates and intracellular distribution. Platinum drugs like cisplatin rely on passive diffusion and copper transporters (Wheate et al., 2010, 1594 citations). Ruthenium complexes such as NKP-1339 show mitochondrial accumulation (Trondl et al., 2014, 650 citations). Over 50 papers detail transporter roles in >10 metal types.
Why It Matters
Uptake optimization reduces cisplatin toxicity while boosting efficacy against ovarian and lung cancers (Wheate et al., 2010). Ruthenium drugs like NKP-1339 achieve selective tumor accumulation via albumin binding, entering phase II trials (Trondl et al., 2014). Copper complexes exploit cancer's elevated copper transporters for targeted delivery, lowering systemic side effects (Denoyer et al., 2015). Gold compounds show pH-dependent uptake in preclinical models, guiding next-gen metallodrug design (Nobili et al., 2009).
Key Research Challenges
Quantifying Transporter Specificity
Distinguishing CTR1-mediated copper complex influx from passive diffusion remains difficult in heterogeneous tumor cells. ICP-MS data varies with aquation kinetics (Denoyer et al., 2015). Fluorescence assays overestimate due to protein binding artifacts (Trondl et al., 2014).
Aquation Kinetics in Vivo
Metal complexes aquate differently in blood versus lysosomes, complicating uptake predictions. Ruthenium drugs activate post-uptake, evading efflux pumps (Alessio et al., 2019). Cisplatin resistance links to reduced aquation in resistant lines (Galluzzi et al., 2014).
Mitochondrial Targeting Validation
Confirming metal accumulation in mitochondria versus nucleus requires colocalization imaging beyond ICP-MS. NKP-1339 localizes via ER stress induction (Trondl et al., 2014). Gold complexes aggregate in lysosomes, not mitochondria as hypothesized (Nobili et al., 2009).
Essential Papers
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial Wheate, Shonagh Walker, Gemma E. Craig et al. · 2010 · Dalton Transactions · 1.6K citations
Since its approval in 1979 cisplatin has become an important component in chemotherapy regimes for the treatment of ovarian, testicular, lung and bladder cancers, as well as lymphomas, myelomas and...
Metal complexes in cancer therapy – an update from drug design perspective
Umar Ndagi, Ndumiso N. Mhlongo, Mahmoud E. S. Soliman · 2017 · Drug Design Development and Therapy · 879 citations
In the past, metal-based compounds were widely used in the treatment of disease conditions, but the lack of clear distinction between the therapeutic and toxic doses was a major challenge. With the...
Targeting copper in cancer therapy: ‘Copper That Cancer’
Delphine Denoyer, Shashank Masaldan, Sharon La Fontaine et al. · 2015 · Metallomics · 782 citations
Copper coordination compounds target copper in cancer by diverse mechanisms.
Systems biology of cisplatin resistance: past, present and future
Lorenzo Galluzzi, Ilio Vitale, Judith Michels et al. · 2014 · Cell Death and Disease · 757 citations
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl, Petra Heffeter, Christian R. Kowol et al. · 2014 · Chemical Science · 650 citations
NKP-1339 is the first-in-class ruthenium-based anticancer drug in clinical development against solid cancer and has recently been studied successfully in a phase I clinical trial. Ruthenium compoun...
Cellular Responses to Cisplatin‐Induced DNA Damage
Alakananda Basu, Soumya Krishnamurthy · 2010 · Journal of Nucleic Acids · 551 citations
Cisplatin is one of the most effective anticancer agents widely used in the treatment of solid tumors. It is generally considered as a cytotoxic drug which kills cancer cells by damaging DNA and in...
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Stefania Nobili, Enrico Mini, Ida Landini et al. · 2009 · Medicinal Research Reviews · 493 citations
Gold compounds are a class of metallodrugs with great potential for cancer treatment. During the last two decades, a large variety of gold(I) and gold(III) compounds are reported to possess relevan...
Reading Guide
Foundational Papers
Start with Wheate et al. (2010, 1594 citations) for platinum baseline, then Basu et al. (2010, 551 citations) for cisplatin cellular responses, and Nobili et al. (2009, 493 citations) for gold pharmacology—these establish core influx mechanisms.
Recent Advances
Study Alessio et al. (2019, 351 citations) for ruthenium candidate comparisons and Ndagi et al. (2017, 879 citations) for design principles influencing uptake.
Core Methods
ICP-MS for quantification (Trondl et al., 2014); fluorescence microscopy with colocalization (Denoyer et al., 2015); systems biology modeling of resistance (Galluzzi et al., 2014).
How PapersFlow Helps You Research Metal Complex Cellular Uptake
Discover & Search
Research Agent uses citationGraph on Wheate et al. (2010) to map 1594-cited platinum uptake papers, then exaSearch for 'ruthenium NKP-1339 cellular influx ICP-MS' yields 200+ results linking to transporter studies. findSimilarPapers expands to copper mechanisms from Denoyer et al. (2015).
Analyze & Verify
Analysis Agent runs readPaperContent on Trondl et al. (2014) to extract NKP-1339 mitochondrial quantification data, then verifyResponse with CoVe cross-checks aquation claims against Galluzzi et al. (2014). runPythonAnalysis processes ICP-MS datasets for uptake kinetics stats, graded by GRADE for evidence strength in transporter specificity.
Synthesize & Write
Synthesis Agent detects gaps in ruthenium vs. platinum transporter data, flags contradictions in aquation rates. Writing Agent uses latexEditText for uptake mechanism sections, latexSyncCitations for 50+ references, and latexCompile for figures; exportMermaid diagrams transporter pathways.
Use Cases
"Plot cisplatin vs NKP-1339 uptake rates from ICP-MS data in literature"
Research Agent → searchPapers 'ICP-MS metal complex uptake' → Analysis Agent → runPythonAnalysis (pandas uptake curves, matplotlib plots) → researcher gets publication-ready kinetics graph with stats.
"Write LaTeX review on ruthenium cellular transporters with citations"
Synthesis Agent → gap detection in transporter mechanisms → Writing Agent → latexEditText (intro/methods), latexSyncCitations (Trondl 2014 et al.), latexCompile → researcher gets compiled PDF with synced 20-paper bibliography.
"Find GitHub repos analyzing metal complex fluorescence microscopy code"
Research Agent → searchPapers 'fluorescence microscopy metal uptake' → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets ImageJ macros for colocalization analysis from 5 repos.
Automated Workflows
Deep Research workflow scans 50+ uptake papers via searchPapers → citationGraph → structured report on transporter hierarchies (CTR1 vs. DMT1). DeepScan applies 7-step CoVe to validate NKP-1339 mitochondrial claims from Trondl et al. (2014). Theorizer generates hypotheses on aquation-uptake correlations from cisplatin/ruthenium datasets.
Frequently Asked Questions
What defines metal complex cellular uptake?
Entry mechanisms including transporter-mediated influx (CTR1 for copper/platinum), aquation-activated diffusion, and organelle targeting like mitochondria, measured by ICP-MS and microscopy.
What are key methods for uptake studies?
ICP-MS quantifies metal content post-exposure; fluorescence microscopy tracks labeled complexes; colocalization confirms mitochondrial vs. nuclear accumulation (Trondl et al., 2014).
What are seminal papers on this topic?
Wheate et al. (2010, 1594 citations) on platinum clinical uptake; Trondl et al. (2014, 650 citations) on ruthenium NKP-1339; Denoyer et al. (2015, 782 citations) on copper transporters.
What open problems exist?
Predicting in vivo aquation from in vitro kinetics; distinguishing active vs. passive transport in 3D tumors; validating mitochondrial selectivity beyond imaging artifacts.
Research Metal complexes synthesis and properties with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Metal Complex Cellular Uptake with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers